Karyopharm Therapeutics Inc (FRA:25K) Stock News, Headlines & Updates
Karyopharm Therapeutics Inc Stock News from GuruFocus
- 1
Jun 03, 2024
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRNewswire • 4:00pm
May 29, 2024
Karyopharm to Participate at the Jefferies Global Healthcare Conference
PRNewswire • 4:00pm
May 09, 2024
Karyopharm Therapeutics Inc (KPTI) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and Capitalizing on Opportunities
GuruFocus Research • 1:02am
Q1 2024 Karyopharm Therapeutics Inc Earnings Call Transcript
GuruFocus Research • 11:25pm
May 08, 2024
Karyopharm to Participate at the 2024 RBC Capital Markets Global Healthcare Conference
PRNewswire • 4:00pm
Karyopharm Therapeutics Reports Q1 2024 Financial Results: A Detailed Review
GuruFocus Research • 7:12am
Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
PRNewswire • 7:00am
Karyopharm Announces Significant Refinancing Transactions and Amended Royalty Agreement Extending Vast Majority of Its Debt Maturities into 2028 and 2029
PRNewswire • 7:00am
May 02, 2024
Karyopharm to Report First Quarter 2024 Financial Results on May 8, 2024
PRNewswire • 4:00pm
May 01, 2024
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRNewswire • 4:00pm
Apr 24, 2024
Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting
PRNewswire • 4:00pm
Apr 01, 2024
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRNewswire • 4:00pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news